Literature DB >> 33139182

PALB2 Variants: Protein Domains and Cancer Susceptibility.

Thales C Nepomuceno1, Marcelo A Carvalho2, Amélie Rodrigue3, Jacques Simard4, Jean-Yves Masson5, Alvaro N A Monteiro6.   

Abstract

Since its discovery, partner and localizer of breast cancer 2 (BRCA2) (PALB2) has emerged as a major tumor suppressor gene linked to breast cancer (BC), pancreatic cancer (PC), and ovarian cancer (OC) susceptibility. Its protein product plays a pivotal role in the maintenance of genome integrity. Here we discuss the first functional evaluation of a large set of PALB2 missense variants of uncertain significance (VUSs). Assessment of 136 VUSs interrogating a range of PALB2 biological functions resulted in the identification of 15 variants with consistent loss of function across different assays. All loss-of-function variants are located at the PALB2 coiled coil (CC) or at the WD40 domain, highlighting the importance of modular domains mechanistically involved in the DNA damage response (DDR) and pinpointing their roles in tumor suppression.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PALB2; breast cancer; genetic testing; ovarian cancer; protein modular domains; susceptibility genes; tumor suppressor; variants of uncertain significance

Mesh:

Substances:

Year:  2020        PMID: 33139182     DOI: 10.1016/j.trecan.2020.10.002

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  6 in total

1.  Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma.

Authors:  Bing Xia; Kajal Biswas; Tzeh K Foo; Thiago T Gomes; Maximilian Riedel-Topper; Eileen Southon; Zhihua Kang; Yanying Huo; Susan Reid; Stacey Stauffer; Weiyin Zhou; Bin Zhu; Hela Koka; Sally Yepes; Seth A Brodie; Kristine Jones; Aurelie Vogt; Bin Zhu; Brian Carter; Neal D Freedman; Belynda Hicks; Meredith Yeager; Stephen J Chanock; Fergus Couch; Dilys M Parry; Alvaro N Monteiro; Alisa M Goldstein; Marcelo A Carvalho; Shyam K Sharan; Xiaohong R Yang
Journal:  Hum Mutat       Date:  2022-07-12       Impact factor: 4.700

2.  Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway.

Authors:  Hui Ma; Zhihua Kang; Tzeh Keong Foo; Zhiyuan Shen; Bing Xia
Journal:  Hepatology       Date:  2022-01-10       Impact factor: 17.298

3.  Somatic DNA Damage Response and Homologous Repair Gene Alterations and Its Association With Tumor Variant Burden in Breast Cancer Patients With Occupational Exposure to Pesticides.

Authors:  Thalita Basso Scandolara; Sara Ferreira Valle; Cristiane Esteves Teixeira; Nicole de Miranda Scherer; Elvismary Molina de Armas; Carolina Furtado; Mariana Boroni; Hellen Dos Santos Jaques; Fernanda Mara Alves; Daniel Rech; Carolina Panis; Cibele Rodrigues Bonvicino
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

4.  Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants.

Authors:  Alberto Valenzuela-Palomo; Elena Bueno-Martínez; Lara Sanoguera-Miralles; Víctor Lorca; Eugenia Fraile-Bethencourt; Ada Esteban-Sánchez; Susana Gómez-Barrero; Sara Carvalho; Jamie Allen; Alicia García-Álvarez; Pedro Pérez-Segura; Leila Dorling; Douglas F Easton; Peter Devilee; Maaike Pg Vreeswijk; Miguel de la Hoya; Eladio A Velasco
Journal:  J Pathol       Date:  2021-12-28       Impact factor: 9.883

5.  PALB2 as a factor to predict the prognosis of patients with skull base chordoma.

Authors:  Yujia Xiong; Mingxuan Li; Yutao Shen; Tianshun Ma; Jiwei Bai; Yazhuo Zhang
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

6.  Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2.

Authors:  Shijie Wu; Lina Qi; Huihui Chen; Kun Zhang; Jiapan He; Xianan Guo; Lu Shen; Yunxiang Zhou; Xi Zhong; Shu Zheng; Jiaojiao Zhou; Yiding Chen
Journal:  NPJ Breast Cancer       Date:  2022-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.